Abiopharma

Annual General Meeting :

Chagee Announces Second Quarter 2026 Unaudited Financial Results

FDA approves Lillys Mounjaro (tirzepatide) to reduce cardiovascular risk in adults with type 2 diabetes

USD.AI Secures $100M Stablecoin Debt Facility From Bullish for GPU Financing

iBio Reports Fiscal Year 2026 Financial Results and Provides Corporate Update

N-able Announces $50 Million Increase to Share Repurchase Program

United Therapeutics Presents Data at The European Society of Cardiology Congress 2026 and The European Respiratory Society International Congress 2026

XORTX Announces Termination and Postponement of Investor Relations Program

Arianne Phosphate Announces Results of Its Annual General Meeting

Owner Raises $240M Led by Goldman Sachs Alternatives to Build the AI-Native Platform for Every Local Business

Chelsea FC and Circle Bring USDC Brands to the Global Game

Altria Announces Election of Steve Presley to Altria’s Board of Directors

Arianne Phosphate annonce les résultats de son assemblée générale annuelle

(99% Neutral) DOLLAR GENERAL CORP (DG) Announces Executive Changes

SEPTEMBER 21, 2026 EQPT INVESTOR DEADLINE: EquipmentShare.com, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit